I doubt the FDA wakes up and thinks about leronlimab first thing in the morning like we do. In fact, I believe most of their communication is through snail mail. So perhaps when the postman delivers the mail to CYDY they will have a nice letter from the FDA stating their case. (I think this because in the past CYDY has had to request face to face meetings, and NP has read letters of response from the FDA to shareholders before)

Even after a response is received, NP and others will have to carefully craft a PR, run it through regulatory folks before posting it. So unless they got it in the mail yesterday, I'm not counting on anything today, and if its the end of the day and a favorable result...I'd wait to PR it until Monday morning.